• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗原、抗体与膜性肾病:十年进展

Antigens, antibodies, and membranous nephropathy: a decade of progress.

机构信息

Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA.

Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA.

出版信息

Kidney Int. 2020 Jan;97(1):29-31. doi: 10.1016/j.kint.2019.10.009.

DOI:10.1016/j.kint.2019.10.009
PMID:31901352
Abstract

Membranous nephropathy (MN) is either primary or associated with various etiologies, each with unique glomerular antigens. The discovery of the phospholipase A2 receptor (PLA2R) antigen in primary MN revolutionized our understanding of MN and led to major clinical progress. Other recently discovered antigens in MN include the THSD7A antigen and exostosin. Sethi et al. have now identified a new antigen, NELL-1, in primary MN, again decreasing the number of patients whose antigen remains unknown.

摘要

膜性肾病(MN)要么是原发性的,要么与各种病因相关,每种病因都有其独特的肾小球抗原。原发性 MN 中磷脂酶 A2 受体(PLA2R)抗原的发现彻底改变了我们对 MN 的认识,并带来了重大的临床进展。MN 中最近发现的其他抗原还包括 THSD7A 抗原和外多核苷酸酶。塞蒂等人现在在原发性 MN 中又发现了一种新的抗原,NELL-1,这再次减少了抗原仍未知的患者数量。

相似文献

1
Antigens, antibodies, and membranous nephropathy: a decade of progress.抗原、抗体与膜性肾病:十年进展
Kidney Int. 2020 Jan;97(1):29-31. doi: 10.1016/j.kint.2019.10.009.
2
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.神经表皮生长因子样 1 蛋白(NELL-1)相关膜性肾病。
Kidney Int. 2020 Jan;97(1):163-174. doi: 10.1016/j.kint.2019.09.014. Epub 2019 Oct 7.
3
Clinical significance of Mtype phospholipase A2 receptor and thrombospondin Type 1 domaincontaining 7A in primary membranous nephropathy.M型磷脂酶A2受体和含血小板反应蛋白1结构域7A在原发性膜性肾病中的临床意义
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jun 28;45(6):693-700. doi: 10.11817/j.issn.1672-7347.2020.190109.
4
Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.磷脂酶 A2 受体和血栓反应蛋白 1 型结构域包含 7A 在恶性肿瘤相关膜性肾病中的特征。
J Clin Pathol. 2019 Oct;72(10):705-711. doi: 10.1136/jclinpath-2019-205852. Epub 2019 Jun 26.
5
Mechanisms of Primary Membranous Nephropathy.原发性膜性肾病的发病机制。
Biomolecules. 2021 Mar 30;11(4):513. doi: 10.3390/biom11040513.
6
A Target Antigen-Based Approach to the Classification of Membranous Nephropathy.基于靶抗原的膜性肾病分类方法。
Mayo Clin Proc. 2021 Mar;96(3):577-591. doi: 10.1016/j.mayocp.2020.11.028.
7
[Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].[含1型血小板反应蛋白结构域7A和神经表皮生长因子样蛋白1在M型磷脂酶A2受体阴性膜性肾病中的临床意义]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2023 Apr;45(2):235-244. doi: 10.3881/j.issn.1000-503X.15212.
8
Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients.中国患者的神经表皮生长因子样 1 蛋白阳性膜性肾病。
Clin J Am Soc Nephrol. 2021 May 8;16(5):727-735. doi: 10.2215/CJN.11860720. Epub 2021 Apr 13.
9
Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.膜性肾病患者肾组织中 PLA2R、THSD7A 和 IgG4 的表达及其与临床特征的相关性。
Int J Clin Pract. 2021 Apr;75(4):e13855. doi: 10.1111/ijcp.13855. Epub 2020 Dec 13.
10
Pathophysiology, diagnosis, and treatment of membranous nephropathy.膜性肾病的病理生理学、诊断和治疗。
Nephrol Ther. 2021 Apr;17S:S1-S10. doi: 10.1016/j.nephro.2021.03.001.

引用本文的文献

1
Antigens in membranous nephropathy: discovery and clinical implications.膜性肾病中的抗原:发现与临床意义
Nat Rev Nephrol. 2025 Jul 21. doi: 10.1038/s41581-025-00980-z.
2
Revolutionizing Autoimmune Kidney Disease Treatment with Chimeric Antigen Receptor-T Cell Therapy.嵌合抗原受体 T 细胞疗法革新自身免疫性肾病治疗
Research (Wash D C). 2025 May 22;8:0712. doi: 10.34133/research.0712. eCollection 2025.
3
Membranous nephropathy: pathogenesis and treatments.膜性肾病:发病机制与治疗
MedComm (2020). 2024 Jun 29;5(7):e614. doi: 10.1002/mco2.614. eCollection 2024 Jul.
4
Segmental Membranous Glomerulopathy in Adults.成人节段性膜性肾小球病
Kidney Dis (Basel). 2023 Aug 8;9(6):507-516. doi: 10.1159/000533294. eCollection 2023 Dec.
5
Backtracking cryptic recurrence of esophageal cancer from membranous nephropathy: the detection of glomerular NELL-1 and IgG4.膜性肾病中食管癌的隐匿性复发回溯:肾小球NELL-1和IgG4的检测
Clin Kidney J. 2022 Dec 7;16(4):756-759. doi: 10.1093/ckj/sfac261. eCollection 2023 Apr.
6
MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy.微小RNA:原发性膜性肾病中细颗粒物2.5与Th17/Treg免疫紊乱之间的潜在介导因子
Front Pharmacol. 2022 Sep 21;13:968256. doi: 10.3389/fphar.2022.968256. eCollection 2022.
7
Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.膜性肾病:基于系统生物学的新机制与中医药治疗
Front Pharmacol. 2022 Sep 13;13:969930. doi: 10.3389/fphar.2022.969930. eCollection 2022.
8
New antigens involved in membranous nephropathy beyond phospholipase A2 receptor.除磷脂酶A2受体外,膜性肾病中涉及的新抗原。
World J Nephrol. 2022 Jul 25;11(4):115-126. doi: 10.5527/wjn.v11.i4.115.
9
Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy.自身抗体在膜性肾病的诊断、监测和治疗中的作用。
Front Immunol. 2021 Mar 22;12:593288. doi: 10.3389/fimmu.2021.593288. eCollection 2021.
10
Mechanisms of Primary Membranous Nephropathy.原发性膜性肾病的发病机制。
Biomolecules. 2021 Mar 30;11(4):513. doi: 10.3390/biom11040513.